This inventor holds 2 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1988.
Company Filing History:
Years Active: 1988
Title: Tomoh Itoh: Innovator in Long Acting Formulations
Introduction
Tomoh Itoh is a distinguished inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of long-acting formulations for hypotensive agents. With a total of 2 patents to his name, his work has the potential to improve patient compliance and treatment outcomes.
Latest Patents
Itoh's latest patents focus on the formulation of amosulalol hydrochloride. The first patent describes long-acting formulations of amosulalol hydrochloride that minimize the frequency of administration of this hypotensive agent. These formulations are prepared by compounding amosulalol hydrochloride with an enterosoluble material, and may also include an organic acid. The second patent reiterates this innovative approach, emphasizing the same formulation techniques to enhance the efficacy and convenience of treatment.
Career Highlights
Tomoh Itoh is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work is characterized by a commitment to improving therapeutic options for patients suffering from hypertension.
Collaborations
Throughout his career, Itoh has collaborated with notable colleagues, including Takashi Sonobe and Hiroshi Sugiura. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.
Conclusion
In summary, Tomoh Itoh is a prominent inventor whose work in long-acting formulations of amosulalol hydrochloride showcases his dedication to advancing pharmaceutical science. His contributions are poised to make a significant impact on patient care and treatment efficacy.